Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20101
20131
20142
20171
20182
20191
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Novo Nordisk A/S3
Australian Catholic University1
Bayside Health1
Bespoke Clinical Research1
Endogenex, Inc.1
Garvan Institute of Medical Research1
Mount Sinai Hospital, Canada1
Samuel Lunenfeld Research Institute, Mount Sinai Hospital1
The George Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 216
Diabetes Mellitus2
Obesity2
Cardiovascular Diseases1
Cognitive Dysfunction1
Dementia1
Diabetes Complications1
Diabetes Mellitus, Type 11
Diabetic Neuropathies1
Hot Flashes1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.